In clinical practice, dose adjustment for SSAs is a common strategy used to manage patients with neuroendocrine tumors (NETs). The primary reason for escalating the dose is to achieve better symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback